ArticleHemaSphere2021

COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment.

Michele Clerico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.